Asian American Medicare Beneficiaries Disproportionately Receive Invasive Mechanical Ventilation When Hospitalized at the End-of-Life

• DOI: 10.1007/s11606-021-06794-6
• Publication Date: 2021-04-26T16:31:08Z
• Authors: Zhimeng Jia; Richard E. Leiter; Justin J. Sanders; Donald R. Sullivan; Pedro Gozalo; Jennifer N. Bunker; Joan M. Teno
• Keywords: Male; Asian; Medicare; Respiration, Artificial; United States; 3. Good health; Death; Hospitalization; 03 medical and health sciences; 0302 clinical medicine; Ethnicity; Humans; Female; Minority Groups; Original Research; Aged; Retrospective Studies

Asian Americans are the fastest-growing ethnic minority in the USA, but we know little about the end-of-life care for this population.Compare invasive mechanical ventilation (IMV) use between older Asian and White decedents with hospitalization in the last 30 days of life.Population-based retrospective cohort study.A 20% random sample of 2000-2017 Medicare fee-for-service decedents who were 66 years or older and had a hospitalization in the last 30 days of life.White and Asian ethnicity as collected by the Social Security Administration.We identified IMV using validated procedural codes. We compared IMV use between Asian and White fee-for-service decedents using random-effects logistic regression analysis, adjusting for sociodemographics, admitting diagnosis, comorbidities, and secular trends.From 2000 to 2017, we identified 2.1 million White (54.5% female, 82.4±8.1 mean age) and 28,328 Asian (50.8% female, 82.6±8.1 mean age) Medicare fee-for-service decedents hospitalized in the last 30 days. Compared to White decedents, Asian fee-for-service decedents have an increased adjusted odds ratio (AOR) of 1.42 (95%CI: 1.38-1.47) for IMV. In sub-analyses, Asians' AOR for IMV differed by admitting diagnoses (cancer AOR=1.32, 95%CI: 1.15-1.51; congestive heart failure AOR=1.75, 95%CI: 1.47-2.08; dementia AOR=1.93, 95%CI: 1.70-2.20; and chronic obstructive pulmonary disease AOR=2.25, 95%CI: 1.76-2.89).Compared to White decedents, Asian Medicare decedents are more likely to receive IMV when hospitalized at the end-of-life, especially among patients with non-cancer admitting diagnoses. Future research to better understand the reasons for these differences and perceived quality of end-of-life care among Asian Americans is urgently needed.